VivoSeq
Other

Neurosurgery

0

Pipeline Programs↗

0

Active Trials↗

0

Companies Involved↗

Neurosurgery is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

0/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

6

clinical trials

Completed6 · 100%

Clinical Trials

Trial Activity

6 trials

Fluid Optimization With Crystalloids and Colloids in Neurosurgery
Completed·UUniversity Medical Centre Ljubljana·N/A·NCT03249298·80 enrolled
Pneumococci and Hib Vaccination After Neurotrauma or Neurosurgery
Completed·UUppsala University·Phase 2·NCT02806284·85 enrolled
The Potential Impact of Clindamycin on Neurosurgery Patients.
Completed·—·N/A·NCT06068673·44 enrolled
The EVICEL® Neurosurgery Phase III Study
Completed·EEthicon, Inc.·Phase 3·NCT02457546·234 enrolled
Cefuroxime vs Ceftriaxone for SSI Prevention in Neurosurgery
Completed·—·Phase 2·NCT05398081·96 enrolled
Topical Vancomycin for Neurosurgery Wound Prophylaxis
Completed·—·Phase 3·NCT02284126·1,103 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)